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Abstract Numerous studies have reported a protective
association between asthma and acute lymphoblastic leu-
kemia (ALL), but the causal structure of this association
remains unclear. We present a hybrid simulation to
examine the compatibility of this association with uncon-
trolled confounding by infection or another unmeasured
factor. We generated a synthetic cohort using inputs on the
interrelations of asthma, ALL, infections, and other sug-
gested risk factors from the literature and the Danish
National Birth Cohort. We computed odds ratios (ORs)
between asthma and ALL in the synthetic cohort with and
without adjustment for infections and other (including
unmeasured) confounders. Only if infection was an extre-
mely strong risk factor for asthma (OR of 10) and an
extremely strong protective factor against ALL (OR of 0.1)
was the asthma-ALL association compatible with the lit-
erature (OR of 0.78). Similarly, strong uncontrolled con-
founding by an unmeasured factor could downwardly bias
the asthma-ALL association, but not enough to replicate
findings in the literature. This investigation illustrates that
the reported protective association between asthma and
ALL is unlikely to be entirely due to uncontrolled con-
founding by infections or an unmeasured confounder alone.
Simulation can be used to advance our understanding of
risk factors for rare outcomes as demonstrated by this
study.
Keywords Asthma  Childhood leukemia  Infection 
Simulation  Risk factors  Confounding
Introduction
Leukemia is the most common childhood cancer, but ion-
izing radiation is the only known environmental cause of
this disease. Many other reproductive and environmental
exposures, including high birth weight, large size for ges-
tational age, tobacco smoke exposure, magnetic fields, and
socioeconomic status (SES) have been suspected as pos-
sible risk factors [1–16], but uncertainty remains.
The possible role of exposure to common infections in
early life in the development of childhood leukemia, par-
ticularly acute lymphoblastic leukemia (ALL) is of interest.
According to the ‘‘population mixing’’ hypothesis [17],
childhood leukemia may develop as a rare response to a
relatively common infection when new infections are
introduced to a previously isolated population. However, the
‘‘delayed infection’’ hypothesis [18] proposes that a relative
lack of early-life infections in modern societies disrupts
normal immune development. This predisposes the immune
system to an aberrant reaction when exposed to infection
later in life, giving a growth advantage to existing pre-leu-
kemic clones and causing progression to leukemia. Based on
the delayed infection infection hypothesis, early exposure to
infection is protective against the development of ALL.
Evidence for a protective effect of infection on ALL
comes largely from epidemiologic studies of proxies for
early-life infection and immune stimulation such as day
care attendance, breast feeding, and birth order. Studies
that directly assessed reports and diagnoses of childhood
infections produced a range of results that tended to be
imprecise and uninformative [19–32]. However, a meta-
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analysis found that day-care attendance, which is thought
to be associated with earlier and more frequent common
infections in childhood, appeared to reduce the risk of
childhood leukemia [33]. Breastfeeding is known to protect
against some infections, and the majority of research sug-
gested it has a protective effect against childhood leukemia
[23, 25, 34–36]. Similarly, most studies reported reduced
risks of ALL with higher birth order and increased
maternal parity, although some results were imprecise [1–
5, 27, 37–46]. A recent pooled analysis of 11 case–control
studies examined the risk of ALL in relation to breast-
feeding, higher birth order, and day care attendance in the
first year of life, and the study reported reduced ALL risk
in relation to each of these exposures [47].
Asthma is a common condition in childhood, and it may
also be the result of anomalous immune system develop-
ment. Family history of asthma and atopy are strong pre-
disposing factors, but they are not sufficient causes of the
condition. Childhood asthma likely originates early in life
when the developing immune and respiratory systems are
especially vulnerable to assault by environmental risk
factors in genetically predisposed individuals [48]. Male
sex and low birth weight have been identified as risk fac-
tors [49, 50], and there is speculation that viral infections of
the lower respiratory tract in early childhood may trigger
the development of asthma, but the mechanism for this is
unclear. It is uncertain whether viral infections cause
asthma, or symptoms of viral infections are more apparent
in asthma-susceptible children [48]. Conversely, some
studies also suggest that upper respiratory tract infections
in early life [49], day care attendance, breast feeding, and
higher birth order may lower asthma risk [51–53].
As both asthma and leukemia may result from abnormal
immune system development, a relationship between these
conditions and possible common causes would be of
interest. Several investigations have reported reduced risks
of childhood ALL in relation to asthma (odds ratio (OR) of
0.5–0.8), although some results were imprecise [19, 23,
54–57]. Two meta-analyses reported summary odds ratios
of 0.79 and 0.82 for the asthma-ALL association, but no
association with acute myeloblastic leukemia was detected
[58, 59]. This protective association could be the result of
infection as a common underlying cause of both conditions.
However, there are a multitude of infectious agents to
which children are exposed and many ways to define and
diagnose infection, making it difficult to pin-point a
specific infection as a cause of both asthma and ALL. The
severity and timing of infection may also be important
considerations, but are assessed at best crudely in epi-
demiologic studies. Studies of both asthma and ALL have
inconsistently (or not at all) accounted for infection.
Another approach for examining infection as a common
underlying cause of both asthma and ALL is with causal
inference and simulation methods. We are not aware of any
studies to date that have tried this approach.
In this investigation, we present a data- and literature-
driven hybrid simulation of the association between child-
hood asthma and ALL, considering the impact of infection
and other potential confounders on this association. We
incorporate information on the observed associations
between exposures and outcomes in the Danish National
Birth Cohort (DNBC) in combination with findings in the
existing literature to account for ‘‘all’’ possible confounders
and biasing paths. The aims of the study are: (1) to simulate a
synthetic cohort integrating published information and data
from an existing cohort on the relations among asthma, ALL,
and their reported or suggested risk factors such as infec-
tions, and (2) to use the synthesized data to conduct simu-
lated experiments examining whether reported associations
between asthma and ALL could be compatible with uncon-
trolled confounding by infections or some other unmeasured
confounding variables.
Methods
We designed and conducted a hybrid simulation study that
generated cohort data using inputs on the interrelations of
asthma, ALL, and infections from an existing cohort
study—the Danish National Birth Cohort (DNBC)—and
from the literature. We then analyzed the simulated cohort
data to investigate whether or not adjusting for the role of
infections with and without further uncontrolled con-
founding could explain the magnitude and direction of the
supposed association between asthma and ALL.
First, we reviewed the literature, paying particular
attention to systematic reviews of interrelations of asthma,
ALL, and infections in the presence of other covariates. A
summary of findings on the association between asthma
and ALL in prior studies is shown in Table 1. We then
constructed directed acyclic graphs (DAGs) to represent
the reported, assumed, or plausible relations between
asthma, ALL, infections, and other covariates, putting a
query on the assumption that asthma causes ALL directly
or indirectly. Competing DAGs were included for further
discussion and justification whenever conflicting literature
suggested as such. Whenever possible, we also extracted
published information on the magnitude and direction of
the associations between the variables.
Second, we analyzed DNBC data to extract information
on the prevalences or incidences of the variables repre-
sented in the DAGs from the previous step and on the
magnitude and direction of the associations between the
variables to the extent possible in the DNBC. The DNBC is
a birth cohort that enrolled 91,661 pregnant women in
M. Sudan et al.
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Denmark between 1996 and 2002, with about 10 %
enrolled more than once during this time period [60]. In
total, 96,841 children were born from these pregnancies
(92,675 singletons). The DNBC has been following the
mothers and children since the prenatal period and has
collected information on their various lifestyle and envi-
ronmental exposures and health characteristics. Data from
the DNBC participants is also linked to the Danish Hospital
Discharge Register, which includes all diagnoses made
during inpatient stays in Danish hospitals or visits to spe-
cialty outpatient clinics. It does not include diagnoses made
during visits to primary care physicians.
Although convincing evidence of a causal relationship
between a common underlying cause and both asthma and
childhood leukemia is lacking, we identified risk factors
which are reportedly associated with both childhood leuke-
mia and asthma. For asthma, we estimated ORs from the
DNBC, where asthma was defined as being diagnosed with
asthma in the hospital register between the ages of 3 and
7 years or being diagnosed with asthma by the age of 7 years
according to the mother’s report. Given the rarity of child-
hood leukemia, we obtained ORs from the literature, using
meta-analyses, when available. Table 2 lists the variables
and the information extracted for this study from singleton-
born children from the DNBC, as well as estimates based on
the literature of risk factors for asthma and ALL.
Third, we used the information on the aforementioned
parameters (that is, on the levels and distributions of the
variables and their interrelations) to simulate data com-
patible with two working DAGs, DAG 1 (Fig. 1) exhibiting
the main assumed causal structure of the asthma-ALL
association and DAG 2 (Fig. 2) exhibiting additional
uncontrolled confounding. We simulated a cohort of
100,000 children using equations with the defined param-
eter values, listed in Table 2. All variables were binary,
drawn from Bernoulli trials, B[1, p], where p was the
probability of observing the variable in the cohort.
In particular, the probability of asthma used in the
simulations was specified as:
1=ð1þ expððlogodds asthmabackground ¼ 1
 
þ log ORinfectionasthmað Þ þ log OReczema=hivesasthma
 
þ log ORmediumSESasthmað Þ þ log ORhighSESasthma
 
þ log ORnormal birthweightasthma
 
þ log ORhigh birthweightasthma
 þ log OR2ndbornasthmað Þ
þ log OR3rd=laterbornasthma
 
þ log ORsexasthmað Þ þ log ORdaycareasthma
 
þ log ORprenatal smokingasthma
 
þ log ORchildhood smoke exposureasthma
 
þ log ORbreastfeedingasthma
 þ log ORUasthmað ÞÞÞ:
Table 2 Input values (odds ratios) for the relationship between
covariates and ALL, Asthma, and infection used to develop the
synthetic cohort
Covariate ALL
(OR)
Asthma
(OR)
Proportion in DNBC
(0\ probability\ 1)
Infection 0.40b 3.00a 0.05
High SES (compared to
low)
1.50b 0.70a 0.67
Medium SES (compared to
low)
1.25b 0.90a 0.29
Eczema/hives 0.70b 2.23a 0.19
High birth weight
(compared to low)
1.30b 0.50b 0.23
Normal birth weight
(compared to low)
1.15b 0.75b 0.74
3rd- or later-born
(compared to 1st-born)
0.85b 0.92a 0.16
2nd-born (compared to
first-born)
0.90b 0.98a 0.74
Male sex 1.27b 1.81a 0.51
Day care 0.80b 0.78a 0.89
Prenatal smoking 1.03b 1.28a 0.34
Childhood smoke exposure 1.16b 1.27a 0.50
Breast feeding 0.84b 0.82a 0.74
Unmeasured factor (U) 3.00 3.00 0.05
1.50 1.50
0.67 0.67
0.33 0.33
ALL acute lymphoblastic leukemia, DNBC Danish national birth
cohort, OR odds ratio, SES socioeconomic status
a Odds ratio value observed in DNBC
b Estimated odds ratio values based on other studies
Asthma [ALL]
Z
(+) (-)
Infecon
Fig. 1 DAG of a main causal structure where infection is a risk factor
for asthma and a protective factor against ALL, and Z is the set of
other measured factors associated with both asthma and ALL. Z
includes SES, eczema/hives, birth weight, birth order, sex, day care
attendance, maternal prenatal smoking, child’s postnatal smoke
exposure, and breast feeding. ALL acute lymphoblastic leukemia,
DAG directed acyclic graph, SES socioeconomic status
M. Sudan et al.
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Similarly, the probability of ALL given asthman and
other covariates was specified as:
1=ð1þ expððlogodds ALLbackground ¼ 1
 
þ log ORasthmaALLð Þ þ log ORinfectionALLð Þ
þ log OReczema=hivesALL
 þ log ORmediumSESALLð Þ
þ log ORhighSESALL
 þ log ORnormal birthweightALL
 
þ log ORhigh birthweightALL
 þ log OR2ndbornALLð Þ
þ log OR3rd=laterbornALL
 þ log ORsexALLð Þ
þ log ORdaycareALL
 þ log ORprenatal smokingALL
 
þ log ORchildhood smoke exposureALL
 
þ log ORbreastfeedingALL
 þ log ORUALLð ÞÞÞ:
The background prevalences for most variables of
interest were based on their prevalences in the DNBC.
However, the background prevalence for asthma was set to
0.1 based on estimates in the literature [61]. The back-
ground cumulative incidence for ALL over 10 years was
set to 0.001, which is higher than the actual known value.
However, some models failed to converge when the
background cumulative incidence was set to 0.0005, and
therefore we increased it as it had no effect on the results of
interest in this study. The background prevalence for U was
set to 0.05. In order to determine if confounding by
infection or other unmeasured confounders could have
produced the asthma-ALL association reported in the lit-
erature, we assumed a true null effect of asthma on ALL
and set ORasthma–ALL = 1.
Using these equations, we drew 1000 Monte Carlo
samples of size 106 each. This was repeated for different
scenarios in which the magnitude and direction of the
infection-ALL association and the infection-asthma asso-
ciation were varied around the values found in the litera-
ture, from 0.1 to 0.9 and from 2 to 10, respectively. For
DAG 1, we analyzed each of the 1000 samples by fitting
one unadjusted and three adjusted logistic regression
models of ALL given asthma. The adjusted models were as
follows: (1) ‘‘minimally-adjusted’’ that adjusted for only
SES and sex because these covariates were commonly
included in previous studies; (2) ‘‘fully-adjusted’’ that
included infection and other causes of ALL as covariates;
and (3) ‘‘fully-adjusted, minus infection’’ that adjusted for
other causes of ALL but omitted infection. For each of the
1000 samples, we saved the odds ratios for the asthma-
ALL association from the models in each scenario. The
resulting 1000 ORs from each model were then summa-
rized to yield the median as the point estimate and their
2.5th and 97.5th percentiles as the 95 % simulation
(uncertainty) interval in each scenario.
The simulation and modeling steps were repeated for
DAG 2, except that the infection-ALL and infection-
asthma associations were held constant at 0.40 and 3.00,
respectively, while the associations between an uncon-
trolled confounder (U) and ALL and between U and
asthma were each varied (OR from 0.33 to 3.00) in the
different scenarios. For DAG 2, we fitted four adjusted
logistic regression models of ALL given asthma: (1)
‘‘minimally-adjusted’’ that adjusted for only SES and sex;
(2) ‘‘fully-adjusted’’ that included infection, U, and other
causes of ALL; (3) ‘‘fully-adjusted, minus U’’ that adjusted
for infection and other causes of ALL but omitted U; and
(4) ‘‘fully-adjusted, minus U and infection’’ that adjusted
for other causes of ALL but omitted U and infection.
Results
The simulated impact of infection on the association
between asthma and ALL is presented in Table 3. Minimal
adjustment for only SES and sex resulted in a slight shift of
the asthma-ALL relationship toward a more negative asso-
ciation. Full adjustment including infection removed the
association completely. Omitting adjustment for infection
reduced but did not completely remove the asthma-ALL
association. Thus, the negative association between asthma
and ALL reported in other studies could only partly be the
result of confounding by infection. The pattern remained the
same regardless of the infection-ALL or the infection-
asthma associations. However, the magnitude of the
asthma–ALL association observed in previous studies (OR
of 0.79–0.82 in meta-analyses) was only observed in our
simulation when infection was an extremely strong risk
factor for asthma (OR of 10) and an extremely strong pro-
tective factor against ALL (OR of 0.1).
In the presence of an unknown confounder, U, where the
U-asthma and U-ALL associations were opposite in
direction, the asthma-ALL association was downwardly
biased (Table 4). Minimal adjustment for only SES and sex
induced an even more downwardly biased association.
Adjustment for all confounders except U and infection had
Asthma [ALL]
Z
(+) (-)
Infecon
U
Fig. 2 DAG of main causal structure with the presence of an
unmeasured risk factor (U) of both asthma and ALL. ALL acute
lymphoblastic leukemia, DAG directed acyclic graph
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a minimal impact on removing the bias due to confound-
ing. Adding infection to the adjustment removed bias
considerably, while only full adjustment brought the
asthma–ALL association back to the null.
Discussion
In this investigation, we used a hybrid approach that
incorporated information about the potential risk factors for
asthma and ALL from the published literature and from
associations in the existing DNBC data to generate a large
synthetic cohort of children. By performing simulation
experiments using our synthesized data, we examined
whether the reported associations between asthma and
ALL could be compatible with uncontrolled confounding
by infections or some other unmeasured confounders.
In our simulations, we were only able to replicate the
asthma-ALL association observed in previous studies (ORof
0.79 to 0.82 in meta-analyses) when we imposed a very
strong positive association between infection and asthma
(OR of 10). Such a strong association between infection and
asthma is not compatible with the OR observed in the DNBC
(OR = 3.0). While a few studies have reported extremely
strong associations (OR[ 10) between early-life hospital-
ization for infection with specific wheeze-associated viral
species (particularly rhinovirus and respiratory syncytial
virus) and later asthma development [62, 63], it is uncertain
whether infection was a cause of asthma in such cases
or if asthma-susceptible children were more likely to show
severe symptoms in response to specific infections that
required hospitalization [64]. The strongest protective
asthma-ALL association we were able to produce
(OR = 0.78) was observed only when ORinfection-ALL = 0.1
and ORinfection-asthma = 10, which is an extreme scenario
that is probably not compatible with reality. In the more
realistic scenarios, where ORinfection-ALL ranged from 0.4 to
0.7 and ORinfection-asthma ranged from 2 to 3, only a slight, if
any, protective asthma-ALL association was observed
(OR[ 0.9).
Table 3 Impact of infection on the association between asthma and ALL
Set Varied inputs OR and 95 % uncertainty interval for Asthma ? ALL
Infect ? ALL
(odds ratio)
Infect ? Asthma
(odds ratio)
Unadjusted Minimally
adjusteda
Fully-adjustedb Fully-adjustedc
(minus infection)
1 0.9 2.0 0.99 (0.81, 1.20) 0.97 (0.79, 1.18) 1.00 (0.82, 1.22) 1.00 (0.82, 1.22)
2 0.9 3.0 0.98 (0.81, 1.19) 0.96 (0.79, 1.17) 1.00 (0.82, 1.22) 0.99 (0.82, 1.21)
3 0.9 5.0 0.98 (0.81, 1.18) 0.96 (0.79, 1.16) 1.00 (0.82, 1.22) 0.99 (0.82, 1.20)
4 0.9 7.0 0.98 (0.81, 1.18) 0.96 (0.79, 1.15) 1.00 (0.83, 1.22) 0.98 (0.82, 1.19)
5 0.7 2.0 0.98 (0.80, 1.19) 0.96 (0.78, 1.17) 1.00 (0.82, 1.22) 0.99 (0.81, 1.21)
6 0.7 3.0 0.97 (0.79, 1.18) 0.95 (0.78, 1.15) 1.00 (0.82, 1.22) 0.98 (0.80, 1.19)
7 0.7 5.0 0.95 (0.78, 1.15) 0.93 (0.77, 1.13) 1.00 (0.82, 1.22) 0.96 (0.79, 1.17)
8 0.7 7.0 0.94 (0.78, 1.14) 0.92 (0.76, 1.12) 1.00 (0.82, 1.22) 0.95 (0.78, 1.15)
9 0.5 2.0 0.97 (0.79, 1.18) 0.95 (0.77, 1.16) 1.00 (0.82, 1.23) 0.98 (0.80, 1.20)
10 0.5 3.0 0.95 (0.78, 1.16) 0.93 (0.76, 1.14) 1.00 (0.82, 1.22) 0.96 (0.78, 1.17)
11 0.5 5.0 0.92 (0.76, 1.12) 0.91 (0.74, 1.10) 1.00 (0.82, 1.22) 0.93 (0.76, 1.14)
12 0.5 7.0 0.91 (0.75, 1.10) 0.89 (0.73, 1.08) 1.00 (0.82, 1.22) 0.91 (0.75, 1.11)
13 0.4 2.0 0.96 (0.79, 1.18) 0.94 (0.77, 1.15) 1.00 (0.82, 1.23) 0.97 (0.79, 1.19)
14 0.4 3.0 0.94 (0.77, 1.15) 0.92 (0.75, 1.13) 1.00 (0.82, 1.23) 0.95 (0.78, 1.16)
15 0.4 5.0 0.91 (0.75, 1.11) 0.89 (0.73, 1.09) 1.00 (0.82, 1.22) 0.92 (0.75, 1.12)
16 0.4 7.0 0.89 (0.73, 1.08) 0.87 (0.72, 1.06) 1.00 (0.82, 1.22) 0.90 (0.73, 1.09)
17 0.2 2.0 0.95 (0.78, 1.17) 0.93 (0.76, 1.15) 1.00 (0.82, 1.23) 0.96 (0.78, 1.18)
18 0.2 3.0 0.92 (0.75, 1.13) 0.91 (0.74, 1.11) 1.00 (0.82, 1.23) 0.93 (0.76, 1.15)
19 0.2 5.0 0.88 (0.72, 1.08) 0.86 (0.71, 1.06) 1.00 (0.82, 1.23) 0.89 (0.73, 1.09)
20 0.2 7.0 0.85 (0.70, 1.04) 0.84 (0.68, 1.02) 1.00 (0.82, 1.23) 0.86 (0.70, 1.05)
21 0.1 10.0 0.80 (0.65, 0.98) 0.78 (0.64, 0.96) 1.00 (0.82, 1.23) 0.80 (0.65, 0.99)
ALL acute lymphoblastic leukemia, Infect infection, OR odds ratio
a Adjusted for ses and sex
b Adjusted for eczema/hives, ses, birthweight, birth order, sex, day-care, prenatal smoking, child’s smoke exposure, breast feeding, and infection
c Adjusted for eczema/hives, ses, birthweight, birth order, sex, day-care, prenatal smoking, child’s smoke exposure, and breast feeding
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The presence of one unmeasured, and therefore uncon-
trolled, confounder is unlikely to explain the protective
association of asthma on ALL. Even in the case where we
imposed strong negative confounding, where ORU-ALL =
3.00 and ORU-asthma = 0.33, we observed an ORasthma-ALL
of 0.86, which is still weaker than the estimates reported in
the literature. The existence of unmeasured negative con-
founding stronger than what we examined here appears
unlikely albeit not impossible. We note that multiple
unmeasured confounding variables will likely introduce
more bias at comparable or even lower bias parameters
than illustrated in this study, provided all the unmeasured
confounders introduce confounding in the same direction
(i.e. all positive or negative but not opposing confounding).
As an illustrative exercise, this study paves the way for
studying how more complicated multiple unmeasured
confounding variables can explain part or all of the
reported asthma–ALL associations. Nonetheless, it should
be noted that increasing the number of unmeasured con-
founding variables presents some challenges. For example,
assuming uncontrolled confounding due to two or more
unmeasured confounding variables makes it challenging to
reason about the nature (and identity) of those variables
while making it easier to explain away a large portion of
the reported asthma–ALL associations.
The associations between risk factors and asthma and
ALL that were used to develop our models are based on
estimates from the DNBC and various studies in the liter-
ature that often contradicted one another. In some cases, we
used our judgement to select estimates that we felt best
represented most findings in the literature or were most
likely to be compatible with reality. For example, while the
association between birth weight and asthma was first
extracted directly from available data in the DNBC, the
result did not follow a dose–response pattern of increased
risk with lower birth weight, as would be expected [50].
Therefore, we used an estimate for the association that we
felt was more consistent the existing literature than with the
DNBC. Similarly, while SES has been examined as a
potential risk factor for ALL in numerous studies, the
findings have been inconsistent overall [15]. We also
considered performing the simulation in two different
ways, one with a negative SES-ALL association, and
another with a positive SES-ALL association. However, as
SES was not the main focus of this investigation, we
decided to use only the positive association in the final
analysis. This choice does not affect our results and the
interpretation of our findings given adjustment for SES in
the models studied here.
As childhood leukemia is a rare, but devastating disease,
and the incidence of asthma has increased in recent years, a
causal relationship between the two conditions would be
remarkable. Such a finding would be groundbreaking for
understanding the development of childhood leukemia and
its underlying risk factors. Therefore, the protective
asthma–ALL association reported in the literature needs to
be examined further. One alternative explanation for the
association may be the presence of multifactorial uncon-
trolled confounding with or without competing risk biases.
For example, asthma will never be detected in children
who die from childhood leukemia before asthma develops.
This could lead to a survivor bias, which may have affected
Table 4 Impact of unmeasured confounding on the association between asthma and ALL
Set Varied inputs OR and 95 % uncertainty interval for Asthma ? ALL
U ? ALL
(OR)
U ? Asthma
(OR)
Unadjusted Minimally
adjusteda
Fully-adjustedb Fully-adjustedc
(minus U)
Fully-adjustedd (minus U
and infection)
1 0.67 3.00 0.92 (0.76, 1.12) 0.90 (0.74, 1.10) 1.00 (0.82, 1.22) 0.98 (0.80, 1.19) 0.93 (0.76, 1.13)
2 0.33 3.00 0.90 (0.73, 1.10) 0.88 (0.72, 1.07) 1.00 (0.82, 1.23) 0.95 (0.77, 1.16) 0.90 (0.74, 1.11)
3 0.67 1.50 0.94 (0.77, 1.14) 0.92 (0.75, 1.12) 1.00 (0.82, 1.23) 0.99 (0.81, 1.22) 0.94 (0.77, 1.16)
4 0.33 1.50 0.93 (0.76, 1.14) 0.91 (0.74, 1.11) 1.00 (0.81, 1.23) 0.98 (0.80, 1.21) 0.94 (0.76, 1.15)
5 3.00 0.67 0.91 (0.75, 1.11) 0.89 (0.74, 1.09) 1.00 (0.82, 1.22) 0.97 (0.80, 1.18) 0.92 (0.76, 1.12)
6 1.50 0.67 0.93 (0.76, 1.14) 0.91 (0.75, 1.12) 1.00 (0.82, 1.22) 0.99 (0.81, 1.21) 0.94 (0.77, 1.15)
7 3.00 0.33 0.88 (0.72, 1.08) 0.86 (0.71, 1.05) 1.00 (0.82, 1.22) 0.94 (0.77, 1.15) 0.89 (0.73, 1.09)
8 1.50 0.33 0.93 (0.76, 1.13) 0.91 (0.74, 1.11) 1.00 (0.81, 1.23) 0.98 (0.80, 1.21) 0.93 (0.76, 1.15)
OR for infection-ALL held constant at 0.40, and OR for infection-asthma held constant at 3.00
ALL acute lymphoblastic leukemia, OR odds ratio
a Adjusted for ses and sex
b Adjusted for eczema/hives, ses, birthweight, birth order, sex, day-care, prenatal smoking, child’s smoke exposure, breast feeding, infection,
and U
c Adjusted for eczema/hives, ses, birthweight, birth order, sex, day-care, prenatal smoking, child’s smoke exposure, breast feeding, and infection
d Adjusted for eczema/hives, ses, birthweight, birth order, sex, day-care, prenatal smoking, child’s smoke exposure, and breast feeding
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previous studies. The previous studies that reported an
asthma–ALL association all used a case–control design,
which is a major limitation of nearly all epidemiologic
studies of childhood leukemia. Case–control studies are
prone to selection bias, which could have affected the
results, and this should be examined. For example, a neg-
ative association between asthma and ALL could be
induced if controls with asthma were more likely to par-
ticipate than healthy controls. Further, it would be infor-
mative to use simulation techniques or other methods to
examine whether the rapid increase in childhood asthma is
compatible with the slight increase in childhood leukemia
in recent years after accounting for other potential con-
founding factors.
Another environmental agent that has been suspected for
several decades as a risk factor for childhood leukemia is
exposure to magnetic fields. While the biological mecha-
nism for an effect of magnetic fields on the development of
childhood leukemia is unclear and unlikely based on basic
biophysics, numerous case–control studies, including three
meta-analyses have consistently reported associations
between residential magnetic field exposure and childhood
leukemia [16, 65, 66]. Once again, it is uncertain whether
these reported associations reflect a true effect or are the
result of selection bias or other sources of bias.
We were able to simulate a very large cohort sample that
was based on numerous parameters extracted from both the
literature and an existing large and well-documented
cohort. The rarity of childhood leukemia makes it difficult
to study its risk factors, and most attempts have been
limited to the case–control study design. There is an urgent
need for new methods to explore the risk factors for
childhood leukemia. While new methods for collecting
data are necessary, bias analysis and simulation methods
offer important approaches for integrating and exploring
relations between childhood leukemia and potential risk
factors. This study offers readers just one example of how
simulation methods can be used to advance our under-
standing and interpretation of childhood leukemia risk
factors, as we demonstrated that the reported associations
between asthma and ALL are unlikely to be due to
uncontrolled confounding by infections or other unmea-
sured confounders.
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